Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Uric Acid and Cardiovascular Disease: An Update
María Lorenza Muiesan, Claudia Agabiti-Rosei, Anna Paini, et al.
European Cardiology Review (2016) Vol. 11, Iss. 1, pp. 54-54
Open Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

Exposure to per- and Polyfluoroalkyl Substances and Markers of Liver Injury: A Systematic Review and Meta-Analysis
E. Jane Costello, Sarah Rock, Nikos Stratakis, et al.
Environmental Health Perspectives (2022) Vol. 130, Iss. 4
Open Access | Times Cited: 242
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events
Marcela V. Maus, S. Alexander, Michael R. Bishop, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e001511-e001511
Open Access | Times Cited: 214
Uric acid and the cardio‐renal effects of SGLT2 inhibitors
Clifford J. Bailey
Diabetes Obesity and Metabolism (2019) Vol. 21, Iss. 6, pp. 1291-1298
Open Access | Times Cited: 162
Progress in Understanding Metabolic Syndrome and Knowledge of Its Complex Pathophysiology
Birendra Kumar Jha, Mingma Sherpa, Mohammad Imran, et al.
Diabetology (2023) Vol. 4, Iss. 2, pp. 134-159
Open Access | Times Cited: 50
Inflammation in heart failure: pathophysiology and therapeutic strategies
Jacinthe Boulet, Vikas S. Sridhar, Nadia Bouabdallaoui, et al.
Inflammation Research (2024) Vol. 73, Iss. 5, pp. 709-723
Open Access | Times Cited: 22
Uric Acid and Plant-Based Nutrition
Boštjan Jakše, Barbara Jakše, Maja Pajek, et al.
Nutrients (2019) Vol. 11, Iss. 8, pp. 1736-1736
Open Access | Times Cited: 105
Large-scale cross-ancestry genome-wide meta-analysis of serum urate
Chamlee Cho, Beomsu Kim, Dan Say Kim, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Transforming Growth Factor-β-mediated attenuation of cardio-renal oxidative stress, inflammation and fibrosis by L-arginine in fludrocortisone acetate induced-hypertensive rats
Abhishek Biswas, Tushar Emran, Sabrin Islam Khan, et al.
European Journal of Pharmacology (2025), pp. 177559-177559
Closed Access | Times Cited: 1
Association of obesity traits and uric acid levels with cardiovascular disease in Punjabi patients from Faisalabad, Pakistan
Muhammad Umer Ghori, Muhammad Shareef Masoud, Muhammad Shafique, et al.
Acta Cardiologica (2025), pp. 1-10
Closed Access | Times Cited: 1
Endothelial dysfunction in neuroprogressive disorders—causes and suggested treatments
Gerwyn Morris, Basant K. Puri, Lisa Olive, et al.
BMC Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 70
A Genome-wide Association Study Discovers 46 Loci of the Human Metabolome in the Hispanic Community Health Study/Study of Latinos
Elena V. Feofanova, Han Chen, Yulin Dai, et al.
The American Journal of Human Genetics (2020) Vol. 107, Iss. 5, pp. 849-863
Open Access | Times Cited: 69
Genetically Determined Uric Acid and the Risk of Cardiovascular and Neurovascular Diseases: A Mendelian Randomization Study of Outcomes Investigated in Randomized Trials
Anthoula Efstathiadou, Dipender Gill, Frances McGrane, et al.
Journal of the American Heart Association (2019) Vol. 8, Iss. 17
Open Access | Times Cited: 57
Association between dyslipidemia and serum uric acid levels in Korean adults: Korea National Health and Nutrition Examination Survey 2016-2017
Minkook Son, Jeongkuk Seo, Sung Yang
PLoS ONE (2020) Vol. 15, Iss. 2, pp. e0228684-e0228684
Open Access | Times Cited: 56
Predictive Value of Serum Uric Acid to HDL Cholesterol Ratio for Incident Ischemic Heart Disease in Non-Diabetic Koreans
Byoungjin Park, Dong‐Hyuk Jung, Yong‐Jae Lee
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1422-1422
Open Access | Times Cited: 37
Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes mellitus
Matthew W. Segar, Ahmed A. Kolkailah, Robert Frederich, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 9, pp. 1829-1839
Open Access | Times Cited: 35
Enzyme-free colorimetric assay for the detection of uric acid in urine by cobalt tetroxide
Jiangfei Cao, Chunsheng Xie, Yi Zeng, et al.
Microchemical Journal (2024) Vol. 204, pp. 111079-111079
Closed Access | Times Cited: 7
Is Uric Acid elevation a random finding or a causative agent of diabetic nephropathy?
Mehmet Zahid Koçak, Gülali Aktaş, Tuba Taslamacıoğlu Duman, et al.
Revista da Associação Médica Brasileira (2019) Vol. 65, Iss. 9, pp. 1155-1160
Open Access | Times Cited: 51
Hyperuricemia and Cardiovascular Risk
Lauren Shahin, Komal M. Patel, Milad K Heydari, et al.
Cureus (2021)
Open Access | Times Cited: 41
Using Innovative Machine Learning Methods to Screen and Identify Predictors of Congenital Heart Diseases
Yanji Qu, Xin Deng, Shao Lin, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 8
Open Access | Times Cited: 26
Association Between Uric Acid, Carotid Intima‐Media Thickness, and Cardiovascular Events: Prospective Results From the IMPROVE Study
Massimo R. Mannarino, Matteo Pirro, Bruna Gigante, et al.
Journal of the American Heart Association (2021) Vol. 10, Iss. 11
Open Access | Times Cited: 29
The Association of Hyperuricemia and Gout With the Risk of Cardiovascular Diseases: A Cohort and Mendelian Randomization Study in UK Biobank
Jianwei Zhu, Yu Zeng, Hanyue Zhang, et al.
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 22
Association of hyperuricemia with cardiovascular diseases: current evidence
Steven G. Chrysant
Hospital Practice (2023) Vol. 51, Iss. 2, pp. 54-63
Closed Access | Times Cited: 13
Potential Underlying Mechanisms Explaining the Cardiorenal Benefits of Sodium–Glucose Cotransporter 2 Inhibitors
Subodh Verma, Sunder Mudaliar, Peter J. Greasley
Advances in Therapy (2023) Vol. 41, Iss. 1, pp. 92-112
Open Access | Times Cited: 13
The combination of high uric acid and high C-reactive protein increased the risk of cardiovascular disease: A 15-year prospective cohort study
Na Li, Shouling Wu, Rong Shu, et al.
Nutrition Metabolism and Cardiovascular Diseases (2024) Vol. 34, Iss. 6, pp. 1508-1517
Closed Access | Times Cited: 4
Uric acid and cardiovascular diseases: a reappraisal
Akruti Patel Prabhakar, Angel López‐Candales
Postgraduate Medicine (2024) Vol. 136, Iss. 6, pp. 615-623
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top